Prevalence, awareness, and burden of major depressive disorder in urban China

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 16, Issue 3, 2016, Pages 393-407

  Gupta, Shaloo ^a   Goren, Amir ^a   Dong, Peng ^b   Liu, Dongdong ^b  

^a KANTAR HEALTH   (United States)

^b PFIZER INC   (United States)

Author keywords

health related quality of life; major depressive disorder; prevalence; productivity loss; resource utilization; urban China

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; AWARENESS; CHINA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER QUESTIONNAIRE; OUTCOME ASSESSMENT; PATIENT HEALTH QUESTIONNAIRE 9; PREVALENCE; PRODUCTIVITY; QUALITY OF LIFE; SCREENING TEST; SELF REPORT; URBAN AREA; ATTITUDE TO HEALTH; COST OF ILLNESS; DEPRESSIVE DISORDER, MAJOR; ECONOMICS; HEALTH SURVEY; MIDDLE AGED; URBAN POPULATION; YOUNG ADULT;

ADULT; CHINA; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; EFFICIENCY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; URBAN POPULATION; YOUNG ADULT;

EID: 84945143771     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/14737167.2016.1102062     Document Type: Article

References (41)

1. th Text Revision ed.). Washington (DC): American Psychiatric Association; 2000.
2. D.Blumenthal, W.Hsiao Lessons from the east—China’s rapidly evolving health care system. N Engl J Med. 2015;372:1281–1285.
3. L.Gu, J.Xie, J.Long, et al. Epidemiology of major depressive disorder in mainland china: a systematic review. PLoS ONE. 2013;8:e65356.Gu et al. conducted a meta-analysis of studies published from 2000-2012 to determine the current, 12-month, and lifetime prevalence of MDD in China by sex and area of residence (rural vs. urban).
4. M.R.Phillips, J.Zhang, Q.Shi, et al. Prevalence, treatment, and associated disability of mental disorder in four provinces in China during 2001-05: an epidemiological survey. Lancet. 2009;373:2041–2053.
5. J.Lu, Y.Ruan, Y.Huang, et al. Major depression in Kunming: prevalence, correlates, and co-morbidity in a south-western city of China. J Affect Disord. 2008;111:221–226.
6. E.Bromet, L.H.Andrade, I.Hwang, et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011;9:90.
7. S.Lee, A.Tsang, Y.Q.Huang, et al. The epidemiology of depression in metropolitan China. Psychol Med. 2009;39:735–747.
8. X.Qin, W.Wang, Q.Jin, et al. Prevalence and rates of recognition of depressive disorders in internal medicine outpatient departments of 23 general hospitals in Shenyang, China. J Affect Disord. 2008;110:46–54.Qin et al. conducted a large outpatients study showing that only 4.0% of depressed patients were diagnosed by a treating physician and only 3.0% were treated for depression.
9. X.Zhou, B.Bi, L.Zheng, et al. The prevalence and risk factors for depression symptoms in a rural Chinese sample population. PLoS ONE. 2014;9:e99692.Zhou et al. found that the prevalence of MDD was high among rural residents, and respondents with more severe MDD symptoms reported poorer HRQoL than those with less severe or mild symptoms.
10. Z.Yan, M.Gu, B.Zhong, et al. Prevalence, risk factors, and recognition rates of depressive disorders among inpatients of tertiary general hospitals in Shanghai, China. J Psychosom Res. 2013;75:65–71.Yan et al. found that, while MDD prevalence was high among hospital in-patients, psychiatrists accurately recognized MDD in less than 20% of those patients with current MDD symptoms.
11. Z.Gan, Y.Li, D.Xie, et al. The impact of educational status on the clinical features of major depressive disorder among Chinese women. J Affect Disord. 2012;136:988–992.
12. Y.Cao, W.Li, J.Shen, et al. Health-related quality of life and symptom severity in Chinese patients with major depressive disorder. Asia Pac Psychiatry. 2013;5:276–283.Cao et al. assessed MDD patients taking anti-depressants over six weeks and determined that more severe symptoms related to poorer HRQoL, but treatment improved these symptoms over baseline.
13. Q.Zeng, Y.Xu, W.C.Wang. Quality of life in outpatients with depression in China. J Affect Disord. 2013;150:513–521.Zeng et al. conducted a survey of over 20,000 out-patients with depression and found that depression symptoms were negatively associated with multiple dimensions of HRQoL.
14. S.Lee, A.Tsang, Y.Huang, et al. Individual and societal impact on earnings associated with serious mental illness in metropolitan China. Psychiatry Res. 2010;180:132–136.
15. T.W.Hu, Y.He, M.Zhang, et al. Economic costs of depression in China. Soc Psychiatry Psychiatr Epidemiol. 2007;42:110–116.
16. S.C.Liao, W.J.Chen, M.B.Lee, et al. Low prevalence of major depressive disorder in Taiwanese adults: Possible explanations and implications. Psychol Med. 2012;42:1227–1237.
17. P.C.Langley, R.Mu, M.Wu, et al. The impact of rheumatoid arthritis on the burden of disease in urban China. J Med Econ. 2011;14:709–719.
18. A.Goren, J.Mould-Quevedo, M.DiBonaventura. Prevalence of pain reporting and associated health outcomes across emerging markets and developed countries. Pain Med. 2014;15:1880–1891.
19. th Asia-Pacific Conference; September2–4, 2012; Taipei (Taiwan)
20. R.M.Hirschfeld, J.B.Williams, R.L.Spitzer, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157:1873–1875.
21. A.K.Cuellar, S.L.Johnson, R.Winters. Distinctions between bipolar and unipolar depression. Clin Psychol Rev. 2005;25(3):307–339.
22. C.De Azevedo-Marques Périco, F.L.Duran, M.V.Zanetti, et al. A population-based morphometric MRI study in patients with first-episode psychotic bipolar disorder: comparison with geographically matched healthy controls and major depressive disorder subjects. Bipolar Disord. 2011;13:28–40.
23. T.D.Zbozinek, R.D.Rose, K.B.Wolitzky-Taylor, et al. Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample. Depress Anxiety. 2012;29:1065–1071.
24. K.Kroenke, R.L.Spitzer, J.B.Williams. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613.
25. M.E.Charlson, P.Pompei, K.L.Ales, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
26. W.JeJr, C.D.Sherbourne. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
27. J.Brazier, J.Roberts, M.Deverill. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271–292.
28. M.E.Maruish. User’s manual for the SF-36v2 Health Survey. 3rd ed. Lincoln (RI): QualityMetric Incorporated; 2011.
29. S.J.Walters, J.E.Brazier. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14:1523–1532.
30. M.C.Reilly, A.S.Zbrozek, E.M.Dukes. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353–365.
31. A.J.Ferrari, F.J.Charlson, R.E.Norman, et al. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease Study 2010. PLoS Med. 2013;10(11):e1001547. doi:10.1371/journal.pmed.1001547
32. P.S.Wang, M.Angermeyer, G.Borges, et al. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization’s world mental health survey initiative. World Psychiatry. 2007;6:177–185.
33. C.S.Lam, B.Angell, H.W.H.Tsang, et al. Chinese lay theory and mental illness stigma: implication for research and practices. J Rehabil. 2010;76:35–40.
34. W.W.S.Mak, S.X.Chen. Illness behaviors among the Chinese. In: M.H.Bond, Ed. Oxford Handbook of Chinese Psychology. New York (NY): Oxford University Press; 2010. p. 421–439.
35. N.Li, W.Du, G.Chen, et al. Mental health service use among Chinese adults with mental disabilities: a national survey. Psychiatr Serv. 2013;64:638–644.
36. X.Yu, S.M.Stewart, P.T.K.Wong, et al. Screening for depression with the Patient Health Questionnaire-2 (PHQ-2) among the general population in Hong Kong. J Affect Disord. 2011;134:444–447.
37. P.Gong, S.Liang, E.J.Carlton, et al. Urbanisation and health in China. Lancet. 2012;379:843–852.
38. Q.Liu. Unemployment and labor force participation in urban China. China Econ Rev. 2012;23:18–33.
39. Y.Chen, K.C.Wu, S.Yousuf, et al. Suicide in Asia: opportunities and challenges. Epidemiol Rev. 2012;34:129–144.
40. Y.C.Shen, M.Y.Zhang, Y.Q.Huang, et al. Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychol Med. 2006;36:257–267.
41. W.J.Guo, A.Tsang, T.Li, et al. Psychiatric epidemiological surveys in China 1960-2010: how real is the increase of mental disorders? Curr Opin Psychiatry. 2011;24:324–330.